Category: Licensing/Collaboration Deal Region: Asia · China Company: Shenzhen Chipscreen Biosciences Ltd

Licensing Partner of Shenzhen Chipscreen Biosciences HUYABIO International Receives Regulatory Approval for Chidamide Monotherapy of Peripheral T-Cell Lymphoma PTCL in Japan

By, Admin 1 min read
Share
Licensing Partner of Shenzhen Chipscreen Biosciences HUYABIO International Receives Regulatory Approval for Chidamide Monotherapy of Peripheral T-Cell Lymphoma PTCL in Japan
SHENZHEN, China, Dec. 1, 2021 /PRNewswire/ -- Shenzhen Chipscreen Biosciences' licensing partner, HUYABIO International (HUYABIO

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!